VISTIN PHARMA ASA earnings
Annual earnings per share (NOK per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2024 | 2024-12-31 | NOK 1.42 | NOK 1.42 | 2026-06-19T06:26:14Z |
| 2023 | 2023-12-31 | NOK 1.03 | NOK 1.03 | 2026-06-19T06:26:14Z |
Revenue & profit (NOK)
| Concept | 2024 | 2023 |
|---|---|---|
| Revenue | NOK 429.1M | NOK 435.4M |
| Profit for the year | NOK 62.7M | NOK 45.6M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in VISTIN PHARMA ASA's ESEF annual reports (source:
filings.xbrl.org).
Figures are in NOK, as reported. Not investment advice.